TY - JOUR
T1 - Generation of furazolidone radical anion and its inhibition by glutathione
AU - Lax, Daniela
AU - Kukolich, Stephen G.
N1 - Funding Information:
This study was supported by the American Heart Association, Arizona Affiliate Grant IG-2-29-90. The results were presented, in part, at the Society for Pediatric Research meeting in New Orleans, Louisiana, May 1991.
PY - 1992/8
Y1 - 1992/8
N2 - Furazolidone is a nitrofuran drug which causes dilated cardiomyopathy in turkeys and serves as an important model of human dilated cardiomyopathy. Although extensively investigated, the chemical mechanism by which furazolidone produces injury remains unknown. In this work we used electron paramagnetic resonance (EPR) spectroscopy to show that furazolidone was reduced to its corresponding nitro anion radical by ascorbate and hypoxanthine. Glutathione prevented the generation of this anion radical. These results document directly, with EPR spectroscopy, the presence of furazolidone anion radical during biochemical reduction and suggest a protective role of glutathione in furazolidone-induced injury. These data enhance our understanding of furazolidone metabolism and may be useful in defining its role in furazolidone-induced dilated cardiomyopathy.
AB - Furazolidone is a nitrofuran drug which causes dilated cardiomyopathy in turkeys and serves as an important model of human dilated cardiomyopathy. Although extensively investigated, the chemical mechanism by which furazolidone produces injury remains unknown. In this work we used electron paramagnetic resonance (EPR) spectroscopy to show that furazolidone was reduced to its corresponding nitro anion radical by ascorbate and hypoxanthine. Glutathione prevented the generation of this anion radical. These results document directly, with EPR spectroscopy, the presence of furazolidone anion radical during biochemical reduction and suggest a protective role of glutathione in furazolidone-induced injury. These data enhance our understanding of furazolidone metabolism and may be useful in defining its role in furazolidone-induced dilated cardiomyopathy.
UR - http://www.scopus.com/inward/record.url?scp=0026783760&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026783760&partnerID=8YFLogxK
U2 - 10.1016/0885-4505(92)90048-4
DO - 10.1016/0885-4505(92)90048-4
M3 - Article
C2 - 1326300
AN - SCOPUS:0026783760
SN - 0885-4505
VL - 48
SP - 56
EP - 63
JO - Biochemical Medicine and Metabolic Biology
JF - Biochemical Medicine and Metabolic Biology
IS - 1
ER -